Learn More
Invitrogen™ JMJD2A Recombinant Rabbit Monoclonal Antibody (6H56L3)
Description
This antibody is predicted to react with Monkey, Cat, and Horse. Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.
Specifications
Specifications
| Antigen | JMJD2A |
| Applications | ChIP Assay, Immunocytochemistry |
| Classification | Recombinant Monoclonal |
| Clone | 6H56L3 |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.09% sodium azide; pH 7.4 |
| Gene | KDM4A |
| Gene Accession No. | O75164 |
| Gene Alias | D4Ertd222e; JHDM3A; jmjC domain-containing histone demethylation protein 3A; JMJD2; JMJD2A; jumonji C domain-containing histone demethylase 3A; jumonji domain containing 2; jumonji domain containing 2A; jumonji domain-containing protein 2A; KDM4A; KIAA0677; lysine (K)-specific demethylase 4A; lysine demethylase 4A; lysine-specific demethylase 4A; mKIAA0677; TDRD14A; tudor domain containing 14A |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.